Zheng et al. demonstrated that silencing IDO in cancer cells prior to implantation resulted in significantly delayed tumor growth and was superior to small molecule inhibitor L-1-Methyltryptophan (1-MT) [68]. Here, IDO1 is linked to neoplasm.